Search results
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Investor's Business Daily· 9 minutes agoModerna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its...
US government, Moderna nearing deal for bird flu vaccine funding: reports
The Hill via Yahoo News· 2 hours agoThe U.S. government is reportedly close to finalizing a deal with Moderna to fund its bird flu mRNA...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters· 5 hours ago, opens new tab mRNA bird flu vaccine, the Financial Times reported on Thursday, as the outbreak...
Moderna's mRNA bird flu vaccine trial is close to getting U.S. government funding
Quartz· 3 hours agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1...
Moderna’s stock climbs on report that bird-flu vaccine funding is near
Market Watch· 5 hours agoModerna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a...
Moderna (NASDAQ:MRNA) Stock Price Down 6.2%
ETF DAILY NEWS· 8 hours agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) shares fell 6.2% during trading on Tuesday . The company traded as low as $156.15 and last traded at $156.26. 873,085 shares ...
Option Trade On Volatile Moderna Stock Could Return 28% By Mid-July
Investor's Business Daily· 6 hours agoThis can be a welcome change for buy-and-hold investors who are reliant on markets always going up....
The Zacks Analyst Blog Highlights NVIDIA, Constellation Energy, Micron Technology, Moderna and...
Zacks via Yahoo Finance· 4 hours agoStocks recently featured in the blog include: NVIDIA Corp. NVDA, Constellation Energy Corp. CEG,...
US Nears Deal To Fund Moderna mRNA Bird Flu Shot Trial, Report Says
Forbes· 12 hours agoThe U.S. government is closing in on a deal to fund a late-stage trial for an mRNA pandemic bird flu...
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 1 day agoWhat began Tuesday as a puzzling dip in shares of the biotech Moderna accelerated into a larger...